Neurocrine Biosciences, Inc. (NBIX) vs Repligen Corporation (RGEN)
Detailed comparison between Neurocrine Biosciences, Inc., Repligen Corporation.Total Return (%)
Neurocrine Biosciences, Inc. (NBIX)Repligen Corporation (RGEN)
Which stock do you think will perform better?
Neurocrine Biosciences, Inc.
NBIX
Repligen Corporation
RGEN
| Metric | Neurocrine Biosciences, Inc. (NBIX) | Repligen Corporation (RGEN) |
|---|---|---|
| Current Price | $140.27 | $124.09 |
| Change | -1.73 (-1.22%) | -1.52 (-1.21%) |
| Market Cap | $13.91B | $6.98B |
| Trailing P/E | 41.50 | 0.00 |
| Forward P/E | 22.59 | 69.71 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $154.61 | $182.52 |
| 52-Week Low | $84.23 | $102.97 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $3.38 | $-0.25 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NBIX | -1.16% | -7.61% | 22.88% | 43.93% | 242.54% | 252.53% |
| RGEN | 2.82% | -25.34% | -14.86% | -17.07% | 359.42% | 345.57% |